DD266735A5 - Verfahren zur herstellung einer racemischen verbindung - Google Patents

Verfahren zur herstellung einer racemischen verbindung Download PDF

Info

Publication number
DD266735A5
DD266735A5 DD87299297A DD29929787A DD266735A5 DD 266735 A5 DD266735 A5 DD 266735A5 DD 87299297 A DD87299297 A DD 87299297A DD 29929787 A DD29929787 A DD 29929787A DD 266735 A5 DD266735 A5 DD 266735A5
Authority
DD
German Democratic Republic
Prior art keywords
hydroxy
product
fluoro
added
water
Prior art date
Application number
DD87299297A
Other languages
German (de)
English (en)
Inventor
Christopher A Lipinski
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD266735A5 publication Critical patent/DD266735A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/322,3-Dihydro derivatives, e.g. flavanones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/96Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DD87299297A 1986-01-17 1987-01-16 Verfahren zur herstellung einer racemischen verbindung DD266735A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1986/000091 WO1987004344A1 (en) 1986-01-17 1986-01-17 Hydroxyacetic acid derivatives for the treatment of diabetic complications

Publications (1)

Publication Number Publication Date
DD266735A5 true DD266735A5 (de) 1989-04-12

Family

ID=22195340

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87299297A DD266735A5 (de) 1986-01-17 1987-01-16 Verfahren zur herstellung einer racemischen verbindung

Country Status (26)

Country Link
US (1) US4853410A (no)
EP (1) EP0230379B1 (no)
JP (1) JPS62169775A (no)
KR (1) KR890004104B1 (no)
CN (1) CN1015545B (no)
AT (1) ATE62237T1 (no)
AU (1) AU574001B2 (no)
CA (1) CA1283119C (no)
DD (1) DD266735A5 (no)
DE (1) DE3768966D1 (no)
DK (1) DK21687A (no)
EG (1) EG18353A (no)
ES (1) ES2022319B3 (no)
FI (1) FI94636C (no)
GR (1) GR3001863T3 (no)
HU (1) HU206618B (no)
IE (1) IE59450B1 (no)
IL (1) IL81261A (no)
NO (1) NO171411C (no)
NZ (1) NZ218970A (no)
PH (2) PH22231A (no)
PL (1) PL148082B1 (no)
PT (1) PT84107B (no)
WO (1) WO1987004344A1 (no)
YU (1) YU46042B (no)
ZA (1) ZA87309B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
AU2440599A (en) * 1998-02-25 1999-09-15 Shionogi & Co., Ltd. Therapeutic agent for complication of diabetes
AT502844B1 (de) * 2005-12-12 2007-08-15 Fronius Int Gmbh Schweissbrenner und endstück sowie kontaktrohr für einen schweissbrenner
JP5654994B2 (ja) * 2008-10-02 2015-01-14 カンブレックス カルルスクーガ アクチ ボラケットCambrex Karlskoga Ab ジケトン及び薬剤を製造するための新しいプロセス
CN105924425B (zh) * 2016-04-29 2018-06-05 浙江师范大学 一种制备二氢硫色满衍生物的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3359161A (en) * 1963-08-29 1967-12-19 Kefalas As Thiaxanthenols, process of producing and anti-tussive compositions thereof
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4210663A (en) * 1978-11-08 1980-07-01 Pfizer Inc. Halogen substituted benzopyran- and benzothiopyran-4-carboxylic acids
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
US4305955A (en) * 1980-10-21 1981-12-15 Pfizer Inc. Carboxylic acid therapeutic agents
ATE11781T1 (de) * 1981-05-13 1985-02-15 Imperial Chemical Industries Plc Pharmazeutische zubereitungen, die spirosuccinimidderivate enthalten.
US4486428A (en) * 1982-03-16 1984-12-04 Pfizer Inc. Bicyclic benzo fused compounds

Also Published As

Publication number Publication date
JPH0586952B2 (no) 1993-12-14
NO873854L (no) 1987-09-15
CN1015545B (zh) 1992-02-19
CN87100191A (zh) 1987-09-09
US4853410A (en) 1989-08-01
FI873843A (fi) 1987-09-04
IL81261A0 (en) 1987-08-31
PL148082B1 (en) 1989-09-30
HU206618B (en) 1992-12-28
KR870007149A (ko) 1987-08-17
CA1283119C (en) 1991-04-16
ES2022319B3 (es) 1991-12-01
NZ218970A (en) 1988-11-29
WO1987004344A1 (en) 1987-07-30
FI873843A0 (fi) 1987-09-04
IE870131L (en) 1987-07-17
NO171411B (no) 1992-11-30
PT84107A (en) 1987-02-01
EG18353A (en) 1993-02-28
IL81261A (en) 1992-05-25
NO171411C (no) 1993-03-10
DK21687D0 (da) 1987-01-16
YU5787A (en) 1988-04-30
PT84107B (pt) 1989-07-31
PH24703A (en) 1990-10-01
FI94636B (fi) 1995-06-30
DE3768966D1 (de) 1991-05-08
EP0230379B1 (en) 1991-04-03
AU574001B2 (en) 1988-06-23
ZA87309B (no) 1988-07-18
JPS62169775A (ja) 1987-07-25
FI94636C (fi) 1995-10-10
NO873854D0 (no) 1987-09-15
PH22231A (en) 1988-07-01
DK21687A (da) 1987-07-18
KR890004104B1 (ko) 1989-10-20
HUT48230A (en) 1989-05-29
YU46042B (sh) 1992-12-21
ATE62237T1 (de) 1991-04-15
PL263678A1 (en) 1988-04-14
EP0230379A3 (en) 1988-10-05
AU6764187A (en) 1987-07-30
IE59450B1 (en) 1994-02-23
GR3001863T3 (en) 1992-11-23
EP0230379A2 (en) 1987-07-29

Similar Documents

Publication Publication Date Title
DE2821966A1 (de) Spiro-hydantoinderivate und ihre verwendung
US3484445A (en) Derivatives of chromone-2-carboxylic acid
EP0340718A1 (de) Chromanderivate
DD146602A5 (de) Verfahren zur herstellung neuer spiro-oxazolidindione
DE2746244A1 (de) Spiro-hydantoin-verbindungen und ihre verwendung
DE3032669A1 (de) Substituierte oxirancarbonsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
EP0415065A1 (de) Chromanderivate
DE2514389A1 (de) 6-oxo-7-substituiert-6h-indeno- (5,4-b)-furan(und thiophen)carbonsaeuren
DD266735A5 (de) Verfahren zur herstellung einer racemischen verbindung
DD294257A5 (de) Verfahren zur herstellung von oxophthalazinyl-essigsaeuren, deren analogen und von zwischenprodukten
EP0072960B1 (de) 1,5-Diphenylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2737407A1 (de) Verfahren zur herstellung neuer benzopyranderivate
DE2461670A1 (de) 5,6-benzo-gamma-pyronderivate, verfahren zu ihrer herstellung und ihre verwendung in pharmazeutischen zubereitungen
DD201890A5 (de) Verfahren zur herstellung neuartiger chinolonverbindungen
DE2804894A1 (de) Halogen-benzofuranon-carbonsaeuren
DD254001A5 (de) Verfahren zur herstellung von heterocyclischen oxophtalazinylessigsaeuren
NZ192650A (en) Spiro-quinolylhydantoins;anti-diabetic agents
CH510009A (de) Verfahren zur Herstellung von neuen heterocyclischen Carbonsäuren
WO1992020671A1 (de) NEUE IN 4-STELLUNG DURCH ARYL ODER N-HETEROARYL SUBSTITUIERTE 2H-BENZO[b]PYRAN-DERIVATE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG SOWIE DIE VERBINDUNGEN ENTHALTENDE ZUBEREITUNGEN
DE1670354A1 (de) Oxazaheterocyclen
EP0071175A2 (de) Phenylalkyloxirancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Anwendung und sie enthaltende Arzneimittel
AT366673B (de) Verfahren zur herstellung neuer phthalazin-4ylessigs[uren und deren salze
DE864554C (de) Verfahren zur Herstellung von Chinoxalin-N, N'-dioxyden
NO164101B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetracykliske spiro-hydantoin-derivater.
EP0594036A1 (de) Arylalkoxythiocumarine, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee